granted patent: Diazene-bridged crown ether lithium compounds and methods for their use

TitleDiazene-bridged crown ether lithium compounds and methods for their use
Granted PatentGB 2437456
Granted Date2009-11-11
Priority Date2005-12-22 PCT/CN2005002282
2004-12-22 US 11/638100P
Inventors
Issue Date2009
Citation
UK Published Patent Application GB 2437456. UK: Intellectual Property Office, 2009 How to Cite?
Abstract
This invention provides a method for treating an eye disease in a patient comprising: providing a photosensitive prodrug that releases upon exposure to light an active ingredient to treat the eye disease; administering the prodrug in a pharmaceutically accepted vehicle to the subject, and exposing the eye of the subject to an external light source to cause the prodrug to release the active ingredient. This invention also provides a composition for the treatment of glaucoma, comprising a compound containing a lithium ion-chelated in a crown ether- or aza-crown ether-containing chromene or diazene derivative and a pharmaceutically acceptable carrier.
Persistent Identifierhttp://hdl.handle.net/10722/142243
References

 

DC FieldValueLanguage
dc.date.accessioned2011-10-19T06:39:51Z-
dc.date.available2011-10-19T06:39:51Z-
dc.date.issued2009-
dc.identifier.citationUK Published Patent Application GB 2437456. UK: Intellectual Property Office, 2009-
dc.identifier.urihttp://hdl.handle.net/10722/142243-
dc.description.abstractThis invention provides a method for treating an eye disease in a patient comprising: providing a photosensitive prodrug that releases upon exposure to light an active ingredient to treat the eye disease; administering the prodrug in a pharmaceutically accepted vehicle to the subject, and exposing the eye of the subject to an external light source to cause the prodrug to release the active ingredient. This invention also provides a composition for the treatment of glaucoma, comprising a compound containing a lithium ion-chelated in a crown ether- or aza-crown ether-containing chromene or diazene derivative and a pharmaceutically acceptable carrier.en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documents-
dc.titleDiazene-bridged crown ether lithium compounds and methods for their useen_HK
dc.typePatenten_US
dc.identifier.emailChe, Chi Ming:cmche@hku.hken_US
dc.identifier.emailSham, Hiu Tung Iona:en_US
dc.identifier.emailSo, Kwok Fai:en_US
dc.identifier.emailVanhoutte, Paul Michel Geo:vanhoutt@hkucc.hku.hken_US
dc.identifier.authorityChe, Chi Ming=rp00670en_US
dc.description.naturepublished_or_final_version-
dc.contributor.inventorPAUL MICHEL GEORGES VANHOUTTEen_HK
dc.contributor.inventorCHIMING CHEen_HK
dc.contributor.inventorKWOKFAI SOen_HK
dc.contributor.inventorHIUTUNG IONA SHAMen_HK
patents.identifier.applicationGB20070014337en_HK
patents.identifier.grantedGB 2437456en_HK
patents.description.assigneeVANHOUTTE PAUL MICHEL GEORGES [CN]; CHE CHIMING [HK]; SO KWOKFAI [CN]; SHAM HIUTUNG IONA [CN]; UNIV HONG KONG [HK]en_HK
patents.description.countryUnited Kingdomen_US
patents.date.granted2009-11-11en_HK
dc.relation.referencesJP 6116280 (A) 1994-04-26en_HK
dc.relation.referencesUS 5132436 (A) 1992-07-21en_HK
dc.relation.referencesUS 5705689 (A) 1998-01-06en_HK
patents.identifier.hkutechidChm-2004-00168en_US
patents.date.application2005-12-22en_HK
patents.date.priority2005-12-22 PCT/CN2005002282en_HK
patents.date.priority2004-12-22 US 11/638100Pen_HK
patents.description.ccGBen_HK
patents.relation.familyCN 101115489 (A) 2008-01-30en_HK
patents.relation.familyDE 112005003183 (T5) 2007-11-08en_HK
patents.relation.familyJP 2008524268 (A) 2008-07-10en_HK
patents.relation.familyUS 2007298127 (A1) 2007-12-27en_HK
patents.relation.familyUS 7468434 (B2) 2008-12-23en_HK
patents.relation.familyWO 2006066511 (A1) 2006-06-29en_HK
patents.description.kindBen_HK
patents.typePatent_granteden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats